| Serial Number | 87271498 |
| Word Mark | TAYTULLA |
| Filing Date | Friday, December 16, 2016 |
| Status | 702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED |
| Status Date | Saturday, January 13, 2024 |
| Registration Number | 5315158 |
| Registration Date | Tuesday, October 24, 2017 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 8, 2017 |
| Description of Mark | The mark consists of the word "Taytulla" above which are two curved lines, the lower of which starts as a pointed thin line above and to the left of the right slanted line of the letter "y" and curves over the letter "t" getting thicker until it ends above and to the right of the left straight line of the letter "u". The second line is above the first line and starts as a thicker line to the left of the pointed lower thin line and curves over the lower line getting thinner until it ends in a thin pointed line between the letters "u" and "l". |
| Goods and Services | Pharmaceutical preparations for the treatment of bacterial infections, pain, cardiovascular system diseases and disorders, respiratory system diseases and disorders, central nervous system diseases and disorders; antidepressants; antipsychotics |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 22, 2016 |
| Primary Code | 005 |
| First Use Anywhere Date | Thursday, November 10, 2016 |
| First Use In Commerce Date | Thursday, November 10, 2016 |
| Party Name | Allergan Pharmaceuticals International Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Coolock, Dublin 17 IE |
| Party Name | Allergan Pharmaceuticals International Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Coolock, Dublin 17 IE |
| Party Name | Allergan Pharmaceuticals International Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Coolock, Dublin 17 IE |
| Event Date | Event Description |
| Saturday, January 13, 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| Saturday, January 13, 2024 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Saturday, January 13, 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Wednesday, July 19, 2023 | TEAS SECTION 8 & 15 RECEIVED |
| Monday, October 24, 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, October 24, 2017 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 8, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 8, 2017 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 19, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, June 29, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, June 9, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, June 8, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 8, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 13, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 13, 2017 | NON-FINAL ACTION E-MAILED |
| Monday, March 13, 2017 | NON-FINAL ACTION WRITTEN |
| Monday, March 13, 2017 | ASSIGNED TO EXAMINER |
| Friday, December 23, 2016 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, December 22, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, December 20, 2016 | NEW APPLICATION ENTERED |